A new study sheds light on the risk of blood clots at all stages of ovarian cancer and the potential need for preventive blood thinners during pre-surgery chemotherapy.

The finding suggests a potential therapy to slow the disease in patients or a possible preventive strategy for women at high risk for ovarian cancer.

New research explains why this difficult-to-treat disease becomes resistant to chemotherapy, suggesting potential future treatment options.